Shanghai Rongtai Health Technology Corporation Limited (603579.SS)

Shanghai Rongtai Health Technology Corporation Limited (603579.SS) — VMCI valuation read

603579.SS screens at VMCI 47/100, a 3-point gap below the Consumer Cyclical sector median (50). For a mid-cap Shanghai Rongtai Health Technology Corporation Limited share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

603579.SS has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: 603579.SS trades at 16.0x earnings, 11% below the Consumer Cyclical median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Consumer Cyclical group. Quality: ROIC of 8.0% trails the Consumer Cyclical median (10.0%) by 2.0pp, the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of -1.0x leaves covenant headroom, which sets the rate-cycle exposure for Shanghai Rongtai Health Technology Corporation Limited.

603579.SS rose 3.2% over the trailing 7 days, with a +2.7% read on a 30-day basis.